IngredientesOleic acid (cis-9-octadecenoic acid) is an omega-9 fatty acid with the molecular formula C18H34O2. In chemical terms, oleic acid is classified as a monounsaturated omega-9 fatty acid, abbreviated with a lipid number of 18:1 cis-9, and a main product of Δ9-desaturase. It has the formula CH3−(CH2)7−CH=CH−(CH2)7−COOH. The name derives from the Latin word oleum, which means oil. Other names encountered in the scientific and regulatory literature include cis-Δ9-octadecenoic acid and (9Z)-octadec-9-enoic acid. The International Union of Pure and Applied Chemistry (IUPAC) name is (Z)-octadec-9-enoic acid. The CAS Registry Number is 112-80-1. The salts and esters of oleic acid are called oleates.
Its molecular formula C18H34O2 and molecular weight of 282.46 g/mol place it within the most studied fatty acids in both natural and synthetic systems. Oleic acid is a solid with a low melting point; two crystalline forms (α-form, melting point 13.4 °C, and β-form, melting point 16.3 °C) are known. It is a long-chain carboxylic acid; its molecule contains one double bond between C9 and C10 with the cis configuration. It is an odorless, colorless oil, although commercial samples may be yellowish due to the presence of impurities. This single double bond creates a 'kink' or bend in the molecule, preventing the chains from packing tightly together. This is why oleic acid is a liquid at room temperature, unlike its saturated counterpart, stearic acid.
Most natural oleic acids have a cis-isomer structure, while trans-isomers are not absorbed by the human body. Treatment with selenium or oxides of nitrogen partially transforms it into the trans isomer elaidic acid.
Oleic acid is a fatty acid that occurs naturally in various animal and vegetable fats and oils. It is the most common fatty acid in nature. It is the most widely distributed of all the natural fatty acids and present in practically all lipids. Fatty acids often do not occur as such in biological systems. Instead, fatty acids such as oleic acid occur as their esters, commonly triglycerides, which are the greasy materials in many natural oils.
It is the main fatty acid in olive oil pressed from the ripe fruit of the olive (Olea europaea). Oleic acid makes up 55–80% of olive oil, 15–20% of grape seed oil and sea buckthorn oil. It also makes up 59–75% of pecan oil, 61% of canola oil, 36–67% of peanut oil, 60% of macadamia oil, 20–80% of sunflower oil, 40% of sesame oil, and 14% of poppyseed oil. High oleic variants of plant sources such as sunflower (~80%) and canola oil (70%) have also been developed. It is abundantly present in many animal fats, constituting 37 to 56% of chicken and turkey fat, and 44 to 47% of lard.
Oleic acid is the most abundant fatty acid in human adipose tissue, and second in abundance in human tissues overall, following palmitic acid. It is also synthesized endogenously in humans from stearic acid through the action of the enzyme stearoyl-CoA desaturase (SCD).
Fatty acids or their salts do not occur in their raw form in biological systems. Instead, fatty acids like oleic acid occur as esters that are the greasy materials in many natural oils. Oleic acid can be found in fats, the phospholipids that make membranes, cholesterol esters, and wax esters. As a dietary supplement and pharmaceutical ingredient, oleic acid is available in the following forms:
The use of the products derived from the olive tree on human health dates back centuries. In several civilizations, the olive tree had and still has a very strong cultural and religious symbolism. Owing to its utility, resilience, and longevity, the olive also held symbolic and spiritual importance in various cultures; its branches and leaves were used in religious rituals, funerary processions, and public ceremonies, from the ancient Olympic games to the coronation of Israelite kings. Ancient Greeks regarded the olive tree as sacred and a symbol of peace, prosperity, and wisdom.
In ancient Egypt, olive oil served both therapeutic and ceremonial purposes. The Ebers Papyrus includes recipes where olive oil, often combined with cedar resin, was used to treat skin ailments, insect bites, joint pain, and even eye infections. Egyptian doctors also mixed olive oil with herbs to improve treatments, relying on its antimicrobial qualities, particularly during embalming processes.
The pottery of the era tells its own story too. By analyzing the residue left inside ancient terracotta jars, known as amphorae, scientists have found traces of oleic acid — the main fatty acid in olive oil. This confirms these vessels were the shipping containers of the ancient world, used to transport liquid gold across sprawling trade networks.
Ancient Romans cultivated olive trees in increasingly marginal landscapes and set up enormous industrial production facilities across the Mediterranean, especially in North Africa and Spain. The Roman historian Pliny the Elder famously declared that, alongside wine and grain, olive oil was an essential necessity of life.
Olive oil plays a major role in religious traditions, particularly in the Bible. It is used to anoint kings, prophets and priests, marking their divine consecration. It also represents blessing, light and peace, as evidenced by the famous image of Noah's dove holding an olive branch, a sign of renewal after the flood. In Judaism, olive oil is used to fuel the menorah, the seven-branched candlestick that is the central symbol of the Temple. Christianity uses it in the sacraments (baptism, confirmation, anointing of the sick) as holy oil, a true link between body and spirit.
Ethnomedical uses of Olea europaea are recorded throughout the world where it has been used to treat various ailments. Phytochemical research has led to the isolation of flavonoids, secoiridoids, iridoids, flavanones, biophenols, triterpenes, benzoic acid derivatives, isochromans, and other classes of secondary metabolites from O. europaea. The plant materials and isolated components have shown a wide spectrum of in vitro and in vivo pharmacological activities like antidiabetic, anticonvulsant, antioxidant, anti-inflammatory, immunomodulatory, analgesic, antimicrobial, antiviral, antihypertensive, anticancer, antihyperglycemic, antinociceptive, gastroprotective, and wound healing activities.
In many Mediterranean cultures, olive oil was an integral part of everyday natural remedies. Ancient healers even immersed patients in olive oil baths to help relieve pain. The skin-emollient and wound-healing properties of olive oil were also applied topically across Greek, Roman, and Arab medical traditions for centuries, valued for their moisturizing and protective effects on the skin.
In biological systems, oleic acid is a major component of cell membranes, helping maintain fluidity and structural integrity. Oleic acid influences cell membrane fluidity, receptors, intracellular signaling pathways, and gene expression. The characteristic cis double bond at the ninth carbon introduces a molecular kink that prevents tight packing of lipid chains, preserving membrane fluidity at physiological temperatures — a property that is fundamental to normal cell signaling and receptor function.
The positive effects of olive oil have often been attributed to its minor components; however, its oleic acid (OA) content (70–80%) is responsible for its many health properties. OA is an effective biomolecule, although the mechanism by which OA mediates beneficial physiological effects is not fully understood.
The anti-inflammatory effect may be related to the inhibition of proinflammatory cytokines and the activation of anti-inflammatory ones. Research shows that oleic acid can reduce the levels of inflammatory cytokines (TNF-α, IL-6, and IL-1β), and molecular docking studies suggested that oleic acid could interact with TLR3 and TLR4 proteins to form ligand–protein complexes, showing good binding affinity. Additionally, oleic acid attenuated the expression of MAPK pathway components (JNK, p38 MAPK) and NF-κB pathway constituents (IκB, NF-κB, COX-2, PGE2).
Many of the beneficial effects attributed to OA may be exerted via PPAR binding. The functions of anti-inflammatory PPARs are mediated by several mechanisms, including NFκB inhibition. OA may directly regulate both the synthesis and activities of antioxidant enzymes.
In macrophages, OA has an anti-inflammatory action. The role of oleic acid in response to inflammatory stimuli involves inhibiting NF-κB signaling pathway by promoting SIRT1 activity on immune cells.
Following food consumption, OEA is synthesized from oleic acid (OA) via an N-acyl phosphatidylethanolamine-specific phospholipase D-dependent pathway in the gastroenterocytes, and OEA induces satiety by recruiting sensory fibers. Thus, dietary OA is an important satiety-inducing molecule. Enterocytes sense oleic acid in dietary fat via CD36 and convert it to OEA through NAPE-PLD dependent or independent pathways. The satiety function of OEA is known to involve peroxisome proliferator-activated receptor-α (PPAR-α). OEA stimulates afferent sensory fibers (possibly those of the vagus nerve) and provokes the recruitment of feeding-controlling circuits in the brain that use oxytocin and histamine as neurotransmitters for regulating satiety.
In vitro results suggest a detrimental role of palmitic acid on the expression of genes related to insulin signaling pathway, with oleic acid being the one with the higher and more beneficial effects. Specifically, p85α was down-regulated after incubation with oleic acid, p110β expression was increased after incubation with oleic acid, and the ratio p85α/p110β was decreased by oleic acid — a pattern consistent with improved PI3K signaling downstream of insulin.
Oleic acid is synthesized endogenously in humans from stearic acid through the action of the enzyme stearoyl-CoA desaturase (SCD). This makes oleic acid a conditionally non-essential fatty acid; it can be derived from both dietary sources and de novo synthesis, though the dietary route is quantitatively the most important in most populations.
Oleic acid's role in cardiovascular health is the most extensively studied area, with evidence including regulatory recognition from the FDA.
FDA Qualified Health Claim: The FDA determined the minimum effective amount of oleic acid in high-oleic acid oils (with at least 70% of oleic acid per serving) necessary to be replaced in place of saturated fatty acids by calculating the difference in the amount of oleic acid, in grams, between the high-oleic acid oils and high-SFA diets from five controlled studies that demonstrated a reduction in total cholesterol (TC) and LDL-C. The lowest difference that was reported in these studies was used to determine the minimum amount of oleic acid necessary to achieve the relevant benefits. To be eligible to bear the qualified health claim, the high-oleic acid-containing oil must contain 5 grams of oleic acid per Reference Amount Customarily Consumed (RACC).
Systematic Review and Meta-Analysis (2026): A meta-analysis of twenty-six trials involving 1,244 participants found that high-oleic diets were associated with modest reductions in total cholesterol (WMD: −0.14; 95% CI: −0.28 to −0.01; I2 = 80.8%) and LDL-C (WMD: −0.13; 95% CI: −0.24 to −0.03; I2 = 64.6%). No significant effects were observed for HDL-C, triglycerides, fasting blood glucose, fasting insulin, or HOMA-IR. The high heterogeneity (I2 up to 80.8%) and modest effect sizes indicate that the evidence, while statistically significant, is not large in absolute magnitude and may be sensitive to study-level factors such as comparator diet, population, and baseline lipid levels.
Comparative trial evidence: Compared with fat high in oleic acid, medium-chain triglyceride (MCT) fat unfavorably affected lipid profiles in healthy young men by increasing plasma LDL cholesterol and triacylglycerol. The total-to-HDL cholesterol ratio was 11.6% higher after industrial trans fatty acids and 10.0% higher after conjugated linoleic acid (CLA) relative to the oleic acid diet in a crossover trial, providing further context for oleic acid's relatively favorable lipid profile compared with these alternatives.
Virgin olive oil and lipoprotein quality: Virgin olive oil (VOO) is thought to play a protective role against cardiovascular disease. Studies have demonstrated a decrease in LDL atherogenicity and an increase in HDL-mediated macrophage cholesterol efflux capacity, HDL antioxidant activity, and HDL anti-inflammatory characteristics after various VOO interventions. However, it must be noted that these effects are attributed to the complex matrix of olive oil (including polyphenols), not oleic acid in isolation.
Circulating oleic acid — a nuanced finding: Limited evidence has suggested that circulating levels of the omega-9 fatty acid, oleic acid, may be related to greater risks of adverse cardiovascular outcomes. The Multi-Ethnic Study of Atherosclerosis measured plasma fatty acids by gas chromatography-flame ionization in 6,568 participants, examining the relationship between circulating oleic acid levels, subclinical cardiovascular disease, and all-cause mortality. This finding highlights an important methodological caveat: circulating plasma oleic acid levels partly reflect endogenous synthesis (via SCD) rather than dietary intake alone, and high SCD activity is associated with metabolic dysregulation. This means the relationship between circulating oleic acid biomarkers and health outcomes may differ substantially from the relationship between dietary oleic acid intake and health outcomes.
PREDIMED trial context: The PREvención con DIeta MEDiterránea (PREDIMED) trial showed that Mediterranean diets supplemented with either extra virgin olive oil or nuts reduced cardiovascular events, particularly stroke, compared with a control, lower-fat diet. Adjusted changes from baseline in mean systolic BP were −2.3 mm Hg (95% CI: −4.0 to −0.5) in the Mediterranean diet with olive oil group and −2.6 mm Hg (95% CI: −4.3 to −0.9) in the Mediterranean diet with nuts group. While oleic acid is a major component of this dietary pattern, these outcomes should be attributed to the whole Mediterranean dietary pattern rather than to oleic acid in isolation.
Research has examined the cellular reactions and intracellular processes triggered by OA in T cells, macrophages, and neutrophils in order to better understand the immune modulation exerted by OA.
Preclinical and mechanistic evidence: The bulk of evidence on oleic acid's direct anti-inflammatory mechanisms comes from in vitro and animal studies. In phagocytic cells, OA reduced LPS-induced acute kidney injury, improving inflammation and oxidative stress via the Ras/MAPKs/PPARγ signaling pathway. It was demonstrated that OA significantly enhanced the expression of nuclear factor erythroid-2 related factor (Nrf-2), which plays a key role in enhancing cytoprotective gene expression.
Assessment of evidence strength: Direct human clinical trial evidence specifically isolating oleic acid's anti-inflammatory action — independent of the full olive oil matrix — remains limited. Most mechanistic anti-inflammatory data are preclinical (cell-based or animal models). Human studies with dietary olive oil show anti-inflammatory markers improve, but attribution to oleic acid specifically versus polyphenols (e.g., oleocanthal, oleuropein) cannot be made from those studies alone.
Research shows that dietary OA is a key factor in the reduction of food intake and increase in satiety mediated by OEA signaling. Oleoylethanolamide (OEA) is a lipid mediator that inhibits food intake by activating the nuclear receptor PPAR-α. In the rodent small intestine, OEA levels decrease during food deprivation and increase upon refeeding, suggesting that endogenous OEA may participate in the regulation of satiety.
OEA has been shown to stimulate the secretion of GLP-1 from the intestinal L-cells. Increased levels of GLP-1 improve insulin secretion in response to meals, reduce glucagon levels, slow gastric emptying, and enhance satiety.
Oleoylethanolamide (OEA), a high-affinity endogenous ligand of nuclear receptor PPAR-α, plays important physiological and metabolic actions. OEA is derived from oleic acid, a monounsaturated fatty acid, which has beneficial effects on body composition and regional fat distribution. The role of OEA in the modulation of food consumption and weight management makes it an attractive molecule requiring further exploration in obesogenic environments.
Evidence strength: The OEA-satiety pathway is well established in preclinical models, with supporting mechanistic evidence in humans (e.g., plasma OEA levels and meal-timing studies). Ten clinical trials (with 11 treatment arms) were eligible for inclusion in a recent systematic review and meta-analysis of OEA supplementation on cardiometabolic health, though these trials studied supplemental OEA rather than oleic acid per se. Direct human RCT evidence showing that oleic acid supplementation alone reliably modulates food intake or body weight is currently limited.
In vitro results suggest a detrimental role of palmitic acid on the expression of genes related to the insulin signaling pathway, with oleic acid being the one with the higher and more beneficial effects. This PI3K pathway modulation is biologically plausible as a mechanism for improved insulin sensitivity.
In the 2026 meta-analysis of 26 RCTs, no significant effects of high-oleic diets were observed for fasting blood glucose, fasting insulin, or HOMA-IR. This finding indicates that, at the level of high-quality RCT evidence analyzed collectively, a dedicated high-oleic diet does not produce statistically significant improvements in glycemic biomarkers compared to control diets — an important qualification to the mechanistic evidence suggesting benefit.
Topical applications of linolenic (n-3), linoleic (n-6), and oleic (n-9) free fatty acids can modulate the closure of surgically induced skin wounds. n-9 FFAs induced faster wound closure when compared to n-3, n-6, and control.
Since unsaturated fatty acids modulate immune responses, researchers evaluated their therapeutic effects on wound healing. Skin wounds were induced in BALB/c mice and treated for 5 days with n-3, n-9 fatty acids, or vehicle. n-9 treated mice presented smaller wounds than control and n-3 at 120 hours post-surgery. Collagen III mRNA, TIMP1, and MMP9 were significantly elevated in the n-9 group compared to n-3 or vehicle at 120 hours. Among the inflammatory mediators studied, IL-10, TNF-α, and IL-17 were also higher in the n-9 treated group. Interestingly, COX-2 had decreased expression in wound tissue treated with n-9. These are animal data and should not be directly extrapolated to human wound healing outcomes.
Skin penetration enhancement: Oleic acid-based infusions, adjuvants, micelles, and vesicles are often used to penetrate the epithelium and enhance the topical delivery of drugs. It is well researched and is used in the pharmaceutical industry as a penetration enhancer. However, oleic acid 18:1(n-9) is toxic to keratinocytes when applied directly, an important consideration in formulation design that has led to its use as a carrier component in small amounts rather than as a primary active agent in topical preparations.
Research evaluated the potential of oleic acid (OA), alongside other polyphenols and ω-3 fatty acids widely present in the Mediterranean diet, to prevent 7-ketocholesterol (50 µM)-induced dysfunction of N2a neuronal cells. When fatty acids were used at non-toxic concentrations (≤25 µM), they greatly reduced 7KC-induced toxicity. The cytoprotective effects observed with polyphenols and fatty acids were comparable to those of α-tocopherol (400 µM) used as a reference. These are in vitro neuronal cell data and must be interpreted as preliminary mechanistic evidence only.
Evidence strength for neuroprotection: Currently, direct neuroprotective evidence for oleic acid in human clinical trials is not established. The existing data are primarily from cell culture models and animal studies.
There is no established recommended dietary allowance (RDA) or tolerable upper intake level (UL) for oleic acid as an isolated nutrient. Dosage information is derived from specific study protocols.
The U.S. FDA has affirmed that oleic acid is GRAS (generally recognized as safe) as a substance migrating from food packaging. The petitioner asserted that oleic acid, as a component of other foods, has a long history of consumption in the United States and around the world. The Select Committee on GRAS Substances (SCOGS) report Number 65 indicates that oleic acid has been used as foods or as components of food, such as olive oil, by man for many years.
Oleic acid 18:1(n-9) is toxic to keratinocytes when applied directly, a finding that is relevant to the design of topical pharmaceutical and cosmetic formulations. This cytotoxicity is concentration-dependent and has led to the use of oleic acid as a penetration-enhancing excipient in controlled concentrations rather than as a standalone topical active in undiluted form.
Feeding of 15% dietary oleic acid to rats in a chronic study resulted in normal growth and general health. No adverse effects at doses consistent with typical dietary intake have been identified in the reviewed evidence.
Limited evidence has suggested that circulating levels of the omega-9 fatty acid, oleic acid, may be related to greater risks of adverse cardiovascular outcomes. This finding warrants careful interpretation: plasma oleic acid levels are substantially determined by endogenous synthesis via SCD-1 activity, which is upregulated in insulin-resistant and obese states, making high plasma oleic acid a potential marker of metabolic dysregulation rather than a direct reflection of dietary oleic acid intake. This mechanistic context means that circulating biomarker associations should not be interpreted as evidence that dietary oleic acid is harmful.
When oleic acid is degraded at high temperatures, it creates negative flavor compounds and diminishes the positive flavors created by the oxidation of linoleic acid. While oleic acid is more thermostable than polyunsaturated fatty acids due to having only one double bond, degradation products at very high frying temperatures may be a consideration in culinary contexts.
No direct pharmacokinetic drug interactions for dietary oleic acid are established in the reviewed literature. However, as oleic acid is a substrate for and modulator of PPAR-α and PPAR-γ pathways, interactions with PPAR-targeting pharmaceutical drugs (e.g., fibrates, thiazolidinediones) represent a theoretically plausible area requiring caution. Similarly, its effects on LDL-C may be additive with lipid-lowering medications, though specific clinical interaction data were not identified in the reviewed sources.
Evidence from randomized controlled trials for high-oleic diets remains inconsistent, and the 2026 meta-analysis reported high heterogeneity (I2 up to 80.8%) in lipid outcomes. Large-scale, long-term randomized clinical trials and Mendelian analyses which assess the lipoprotein state and properties are required to confirm results from olive oil and high-oleic diet intervention studies. Anti-inflammatory and neuroprotective mechanisms of oleic acid remain largely characterized in preclinical settings, with a relative paucity of well-controlled human trials targeting oleic acid in isolation.
Condiciones de salud que ácido oleico puede ayudar a apoyar.
Oleic acid enrichment of LDL particles renders them significantly more resistant to oxidative modification compared to particles rich in polyunsaturated fatty acids, a well-documented antioxidant mechanism. Human studies confirm that oleic acid-enriched diets reduce circulating oxidised LDL. OEA supplementation RCTs also document reductions in oxidative stress markers.
Oleic acid is the dietary precursor to oleoylethanolamide (OEA), an endogenous lipid mediator produced in the small intestinal wall after fat ingestion. OEA activates PPAR-α receptors and vagal sensory fibers to signal satiety to the brainstem and hypothalamus. Early human evidence and a 2025 systematic review and meta-analysis of RCTs indicate OEA supplementation is associated with reduced hunger and modest weight loss in overweight individuals.
Dietary oleic acid, when substituted for saturated fats, is associated with improved endothelial function and reduced coronary heart disease risk. The FDA issued a qualified health claim for oleic acid in edible oils after a systematic review found credible evidence for reduced CHD risk. LDL particles enriched with oleic acid are also less susceptible to oxidation, a key mechanism in atherosclerosis.
Dietary oleic acid consumption has been associated with blood pressure reduction in some human studies, though results are inconsistent. An epidemiological review noted that oleic acid consumption may reduce blood pressure and CVD risk, while RCTs show modest or non-significant effects. A direct comparison crossover study found borderline non-significant differences between oleic and linoleic acid-supplemented diets.
Oleic acid-rich diets have been associated with modest improvements in fasting glucose and insulin sensitivity in human studies, particularly in diabetic and at-risk populations. A PubMed-indexed study found a small but significant decrease in fasting glucose/insulin ratio following an oleic acid-rich dietary intervention. A 2021 systematic review found olive oil and oleic acid intake associated with beneficial effects on components of metabolic syndrome including glucose control.
Dietary oleic acid reliably lowers LDL cholesterol and maintains or raises HDL when substituted for saturated or trans fats, supported by multiple RCTs and systematic reviews. An RCT of 61 healthy adults showed significantly lower LDL after an oleic acid diet versus industrial trans fat diet (2.68 vs 3.00 mmol/L, p<0.001). The FDA's qualified health claim for oleic acid in edible oils is based in part on this cholesterol-modifying evidence.
Oleic acid and its derivative OEA exert anti-inflammatory effects through PPAR-α activation and downregulation of pro-inflammatory cytokines. Human dietary trials with oleic acid-rich oils show reductions in inflammatory markers in at-risk populations. OEA supplementation RCTs document improvements in inflammation and oxidative stress markers.
Oleic acid produced endogenously in the brain has been identified as an essential regulator of neurogenesis, learning, and memory in a study published in the Proceedings of the National Academy of Sciences. A Japanese cohort study found associations between oleic acid consumption and preservation of cognitive function in the elderly. A 2025 systematic review also found oleic acid among olive oil bioactive components that may contribute to neuroprotection.
Oleic acid is a major constituent of the skin's natural lipid barrier and is used topically to replenish lost lipids and improve skin hydration. It penetrates deeply into skin layers and helps restore barrier function. Clinical and ex-vivo studies confirm that unsaturated fatty acids including oleic acid contribute to maintaining and restoring the skin's lipid barrier.
Oleic acid has documented anti-inflammatory activity in irritant contact dermatitis models and is incorporated into topical formulations for eczema-prone skin. Preclinical studies show oleic acid reduces oedema and cytokine release in skin inflammation models. The relationship is mixed—high oleic acid concentrations may impair barrier function in susceptible individuals, but formulated products show benefit.
Diets enriched in oleic acid (MUFA) have been associated with favourable body composition outcomes compared to diets high in saturated or polyunsaturated fats in several human intervention studies. A systematic review of human trials found that high-oleic acid diets led to reduced adiposity, particularly android fat mass, versus PUFA-rich diets. OEA, synthesised from oleic acid, also plays a role in appetite suppression and fat oxidation.
The FDA issued a qualified health claim that oleic acid in edible oils may reduce the risk of coronary heart disease when substituted for saturated fats. Multiple RCTs show oleic acid lowers LDL cholesterol and improves HDL-to-total-cholesterol ratios. Large cohort and dietary intervention studies consistently support a protective role for dietary oleic acid intake on coronary heart disease outcomes.
A 2021 systematic review and meta-analysis of human trials found that olive oil and oleic acid intake have beneficial effects on the key components of metabolic syndrome, including dyslipidaemia, insulin resistance, hypertension, and obesity. OEA, the primary bioactive metabolite of oleic acid, addresses inflammation, triglyceride dysregulation, glycaemic control, and insulin resistance—all core MetS features.
Research published in the Journal of Investigative Dermatology found that oleic acid-rich skin is less likely to experience psoriasis resurgence by suppressing activity of tissue-resident memory T cells, which drive psoriatic relapses. Oleic acid modulates T-cell membrane fatty acid composition to reduce their functional persistence. Clinical safety data also document that topical oleogel formulations have been studied in psoriasis patients.
Oleic acid's role in antioxidant protection of LDL particles extends to protecting skin cell membranes from oxidative damage, which contributes to photoaging and wrinkle formation. Topical oleic acid replenishes skin lipids depleted by UV exposure and aging. Its integration into cell membranes helps preserve structural integrity and delay age-related skin changes.
Oleic acid modulates the immune response in wound healing and is documented to promote fibroblast activity and collagen synthesis in the skin repair process. A 2010 ScienceDirect review established oleic acid's role in modulating immune responses during skin repair, with downstream effects on collagen deposition. Topical application in wound healing models shows increased collagen synthesis.
OEA, synthesised from oleic acid, is established to reduce serum triglycerides through PPAR-α activation. A 2025 systematic review and meta-analysis of RCTs on OEA supplementation found significant triglyceride-lowering effects. High-oleic oil dietary interventions also show reductions in serum triglycerides compared to saturated fat diets.
Oleic acid is documented to modulate the immune response during wound healing and promote resolution of the inflammatory phase, facilitating transition to proliferation and tissue remodelling. Multiple preclinical and clinical studies confirm topical oleic acid accelerates healing of chronic skin wounds by modulating inflammatory cell activity and supporting epithelialisation.
Sistemas corporales que ácido oleico puede ayudar a apoyar.
Volver